Navigation Links
Polyneuropathy in Medical News

CIDP Treated With Plasma-Derived Therapy

... Patients with rare, chronic inflammatory demyelinating polyneuropathy (CIDP) depend on plasma donation ANNAPOLIS, Md. , April 24 /PRNewswire/ -- Chronic inflammatory demyelinating polyneuropathy (CIDP) is a debilitating, progressive neurological disorder that results ...

Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019

... SF-1019 in the treatment of Diabetic Ulceration and its effect on Diabetic polyneuropathy in Type 1 Diabetes Mellitus by both subcutaneous injection and by topical ... (MS) and neurological disorders such as Chronic Inflammatory Demyelinating polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS). (For more ...

NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors

... management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch ...

NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)

... management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch ...

GBS/CIDP Foundation International Appoints Patricia A. Bryant as Executive Director

... the only non-profit organization dedicated to serving patients afflicted with Guillain-Barre Syndrome (GBS), Chronic Inflammatory Demyelinating polyneuropathy (CIDP) and variants, announced the appointment of Patricia A. Bryant to the position of Executive Director effective as of May 2009. Patricia ...

New Jefferson study may redefine how a chronic auto-immune disease is diagnosed

... PHILADELPHIA New research from Jefferson Hospital for Neuroscience (JHN) may redefine how Chronic Inflammatory Demyelinating polyneuropathy (CIDP) is diagnosed. Eduardo De Sousa, M.D., assistant professor of Neurology at Jefferson Medical College of Thomas Jefferson University, and ...

NORD to Honor Rare Disease Pioneers

... Talecris Biotherapeutics, Inc., for developing Gamunex(R), the first therapy approved for treating people with chronic inflammatory demyelinating polyneuropathy ViroPharma, Inc., for making available to patients Cinryze(R), the first drug approved by FDA to prevent swelling that occurs in various body ...

Landmark study demonstrates Gamunex improves health-related quality of life in patients with CIDP

... of the health-related quality of life results from the largest clinical trial ever conducted in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) in the April 14, 2009 issue of Neurology . The data demonstrate that long-term treatment with Gamunex (Immune Globulin Intravenous (Human), ...

Type of vitamin B1 could treat common cause of blindness

... trials have shown that benfotiamene is absorbed better than thiamine [the most common form of vitamin B1] and significantly improved diabetic polyneuropathy in patients, and it's already taken as a supplement for diabetic complications," Ramana said. ...

NeurogesX Reports Fourth Quarter and Year-End 2008 Results

... management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late-stage product portfolio is led by its product candidate Qutenza(TM), a dermal ...
Polyneuropathy in Medical Technology

NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology

... study involving 307 patients with painful HIV-associated distal sensory polyneuropathy (HIV-DSP) receiving a single application of NGX-4010, a high-concentration ... pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage ...

Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019

... SF-1019 in the treatment of Diabetic Ulceration and its effect on Diabetic polyneuropathy in Type 1 Diabetes Mellitus by both subcutaneous injection and by topical ... (MS) and neurological disorders such as Chronic Inflammatory Demyelinating polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS). (For more ...

Immunosyn Corporation Releases SF-1019 Study Results

... review included but were not limited to Chronic Inflammatory Demyelinating polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy (RSD or RSDS). The summary ... (MS) and neurological disorders such as Chronic Inflammatory Demyelinating polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS). (For more ...

NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study

... management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch ...

NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia

... management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch ...

NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology

... management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late-stage product portfolio is led by its product candidate Qutenza, a dermal patch ...

NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation

... management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch ...

NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP

... from study C119, its second Phase 3 clinical trial of NGX-4010, the Company's dermal patch drug candidate, in patients with HIV-distal sensory polyneuropathy (HIV-DSP). The prespecified analysis of the primary endpoint, comparing all patients treated with NGX-4010 compared to all patients treated with the ...

Immunosyn Announces Biozyme Lab's Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019

... and diabetic ulcers (DU), auto-immune disorders such as Multiple Sclerosis (MS) and neurological disorders such as Chronic Inflammatory Demyelinating polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS). (For more information on Immunosyn and SF-1019 go to http://www.immunosyn.com ). ...
Polyneuropathy in Medical Dictionary

Polyneuropathy

... polyneuropathy implies a widespread process that usually ... equally. The cause of chronic inflammatory polyneuropathy is an abnormal immune response . Sensorimotor polyneuropathy is a form of peripheral neuropathy (damage to ...

Chemical pneumonitis

... chemical pneumonitis acute confusion al state acute demyelinating polyneuropathy acute febrile illness acute glaucoma acute ... leukemia acute idiopathic poly neuritis acute idiopathic polyneuropathy ... ...

Chronic Granulomatous Disease

... of bacteria . chronic granulomatous disease chronic inflammatory polyneuropathy chronic kidney failure chronic obstructive pulmonary disease ... Leukemia ( CML )) Chronic Granulomatous Disease Chronic Inflammatory polyneuropathy Chronic Insomnia ( Primary Insomnia ) ... of this neurologic ...

Confusion

... infection ... acute confusion al state acute demyelinating polyneuropathy acute febrile illness acute glaucoma acute ... leukemia acute idiopathic poly neuritis acute idiopathic polyneuropathy acute intermittent porphyria ... =being out of the mind], ...

Alcoholic ketoacidosis

... . Alcoholic Encephalopathy (Wernicke-Korsakoff Syndrome ) Alcoholic Ketoacidosis Alcoholic Liver Disease Alcoholic Neuropathy Alcoholic polyneuropathy ( Alcoholic Neuropathy ) ... ...

Alcoholic liver disease

... Please discuss any and all treatment options with your healthcare professional. Alcoholic Liver Disease Alcoholic Neuropathy Alcoholic polyneuropathy ( Alcoholic Neuropathy ) Alcoholism Alcoholism - Resources ... It frequently appears in association with alcoholic liver disease , ...

Chromosome

... chronic chronic active hepatitis chronic fatigue syndrome chronic glaucoma chronic granulomatous disease chronic inflammatory polyneuropathy chronic kidney failure chronic obstructive pulmonary disease ... symptomatic ; parkinson ian; parkinsonism ; Parkinson , James; ...

Chronic gouty arthritis

... Gouty Arthritis Chronic Granulocytic Leukemia ( Chronic Myelogenous Leukemia ( CML )) Chronic Granulomatous Disease Chronic Inflammatory polyneuropathy Chronic Insomnia ( Primary Insomnia ) ... Side effects of medications Chronic gouty arthritis Kidney stones Kidney dysfunction ... ...

Corticosteroids

... version. Corticosteroids can reduce swelling , pain , and other manifestations of inflammation . CPID: See Chronic Idiopathic Demyelinating polyneuropathy . Patients with a prior allergic reaction to contrast dye or medication and patients who have asthma , emphysema , or heart disease are at ...

Distal

... wrist joint due to a fall on an outstretched hand . Most of the neurologic attention in diabetes mellitus has focused on distal symmetric polyneuropathy (DSP) -- abnormalities of the peripheral nerve s, in particular, the nerve s to the feet and hands. The flexor digit orum longus muscle ...

More>>

Polyneuropathy in Biological Technology

NeurogesX Receives European Commission Approval for Qutenza(TM)

... in cases of postherpetic neuralgia (PHN) and painful HIV-distal sensory polyneuropathy (HIV-DSP), or diseases, such as diabetes. An estimated 8% of the ... pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage ...

NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union

... in cases of postherpetic neuralgia (PHN) and painful HIV-distal sensory polyneuropathy (HIV-DSP), or diseases, such as diabetes. An estimated 8% of the ... pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage ...

NeurogesX Reports Second Quarter 2008 Results

... studies of NGX-4010 in other indications (e.g., HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN), where it is likely that ... pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage ...

Immunosyn Corporation Files 10-Q

... including Multiple Sclerosis (MS), Chronic Inflammatory Demyelinating polyneuropathy (CIDP), Reflex Sympathetic Dystrophy Syndrome, (RSD or RSDS) and other ... (MS) and neurological disorders such as Chronic Inflammatory Demyelinating polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS). The ...

Immunosyn Corporation Announces 2007 Results, Files 10KSB

... including Multiple Sclerosis (MS), Chronic Inflammatory Demyelinating polyneuropathy (CIDP), Reflex Sympathetic Dystrophy Syndrome, (RSD or RSDS) and other ... (MS) and neurological disorders such as Chronic Inflammatory Demyelinating polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS). The ...

Immunosyn Corporation to Present at FSX

... including Multiple Sclerosis (MS), Chronic Inflammatory Demyelinating polyneuropathy (CIDP), Reflex Sympathetic Dystrophy Syndrome, (RSD or RSDS) and other ... (MS), neurological disorders such as Chronic Inflammatory Demyelinating polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS) and ...

NeurogesX Reports Second Quarter 2009 Results

... management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), a dermal patch ...

NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application

... management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), a dermal patch ...

NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results

... management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza((TM)), a dermal ...

NeurogesX Added to Russell 3000 Index

... management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch ...
Other Contents
(Date:1/22/2015)... 2015 LunaDress, with its top dressmaking technologies, ... Now, the business is showing its latest designs of wedding ... According to the company’s CEO, all the fresh new products ... big discounts, up to 80% off. All the clothes from ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located ... the number one best large hotel for families in the ... their annual Travelers’ Choice Awards. , TripAdvisor represents the ... home to millions of unbiased and honest traveler reviews. The ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, AZ ... Alliance (PPHA). The PPHA's passion for others' well-being and ... greats, treated for obstructive sleep apnea (OSA) has propelled them ... in the valley. The most recent plans for an event ...
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 The Incredible ... Bodybuilder Ben Pakulski to increase lean muscle by up to ... has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an ... that it is a step-by-step, scientific diet formula that allows ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Blue Cross and ... Minnesotans who exemplify what it means to “Live Fearless.” ... for people to share their stories about how they or ... simply inspired others by living in the moment. By telling ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2
(Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first decentralized ... and Internet of Things era, today announced the close ... round was led by Metamorphic Ventures with participation from ... VegasTechFund, and others.  LaunchKey has raised $4 million to ...
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM announced today ... to confirm its adherence to current U.S. Food and ... conduct regulated smart device and smart phone application trials ... quality. "HITLAB is determined to improve global ...
(Date:12/17/2014)... is fundamentally transforming the travel experience and nowhere is ... past decade, ePassports, biometric readers, and secure document scanners ... control via eGates and Automated Passport Control (APC) Kiosks ... borders across the globe. According to ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
Other TagsOther Tags